Re­pub­li­can sen­a­tors slam pro­posed ac­cel­er­at­ed ap­proval pay­ment re­forms

Re­pub­li­can sen­a­tors are speak­ing out against a pro­posed test mod­el in which drug­mak­ers would ef­fec­tive­ly make less for drugs ap­proved via the FDA’s ac­cel­er­at­ed ap­proval.

The test pro­gram, dubbed the Ac­cel­er­at­ing Clin­i­cal Ev­i­dence Mod­el, was an­nounced last month as a way to in­cen­tivize quick­er con­fir­ma­to­ry tri­als and “re­duce Medicare spend­ing on drugs that have no con­firmed clin­i­cal ben­e­fit.” HHS Sec­re­tary Xavier Be­cer­ra di­rect­ed CMS to be­gin con­sul­ta­tion with the FDA on the mod­el this year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.